<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Astrid van Tubergen, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joachim Sieper, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Philip Seo, MD, MHS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Axial spondyloarthritis (axSpA) is a potentially disabling inflammatory arthritis of the spine, usually presenting as chronic back pain, almost always before the age of 45. It is often associated with one or more of several articular and periarticular extraspinal features, including synovitis, enthesitis, and dactylitis. It may also be associated with several nonarticular features; these include uveitis, psoriasis, and inflammatory bowel disease (IBD). Patients frequently carry the gene for human leukocyte antigen (HLA) B27, and patients with active inflammatory disease may have evidence of an elevated acute phase response [
         <a href="#rid1">
          1
         </a>
         ]. However, axSpA is a syndrome with an evolving definition encompassing a spectrum of features and without highly characteristic biomarkers such as those found in rheumatoid arthritis and diabetes [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Patients with axSpA can be classified as having either of two subtypes of axSpA: ankylosing spondylitis (AS, also termed radiographic axSpA) or nonradiographic axSpA (nr-axSpA) [
         <a href="#rid3">
          3
         </a>
         ]. Patients with AS exhibit radiographic abnormalities consistent with sacroiliitis, but such findings are absent or minimal on plain radiography in nr-axSpA. Instead, in patients with nr-axSpA, the diagnosis is supported by evidence of active inflammation of the sacroiliac (SI) joints on magnetic resonance imaging (MRI), by a combination of other findings, or both. Such subclassification might be rather arbitrary, and many experts understand axSpA as a continuum rather than having two separate distinct entities [
         <a href="#rid4">
          4
         </a>
         ]. In clinical practice, a distinction between these two forms of axSpA in an individual patient has limited impact on disease burden and management and may not be relevant [
         <a href="#rid5">
          5
         </a>
         ], although the classification may be of value for epidemiologic and other investigative purposes [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="local">
          'Nomenclature and classification'
         </a>
         below.)
        </p>
        <p>
         The clinical manifestations of axSpA will be reviewed here. The pathogenesis, diagnostic evaluation, and treatment of this disorder in adults are discussed separately, as is spondyloarthritis (SpA) in children. (See
         <a class="medical medical_review" href="/z/d/html/7792.html" rel="external">
          "Pathogenesis of spondyloarthritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7790.html" rel="external">
          "Treatment of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6421.html" rel="external">
          "Spondyloarthritis in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H35266036">
         <span class="h1">
          NOMENCLATURE AND CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A 2009 classification study divided axial spondyloarthritis (axSpA) into ankylosing spondylitis (AS, also termed radiographic axSpA) and nonradiographic axSpA (nr-axSpA). Historically, spondyloarthritis (SpA, also termed spondyloarthropathy) has been regarded as a family of arthritides that includes AS; undifferentiated SpA; reactive arthritis; psoriatic arthritis; juvenile SpA; and arthritis and spondylitis associated with inflammatory bowel disease (IBD), including Crohn disease and ulcerative colitis [
         <a href="#rid7">
          7
         </a>
         ]. Traditionally, AS has been regarded as the prototype of SpA, and the majority of publications prior to 2009 on SpA focused on AS. (See
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6421.html" rel="external">
          "Spondyloarthritis in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">
          "Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"
         </a>
         .)
        </p>
        <p>
         The term "axial spondyloarthritis" (axSpA) became standard nomenclature in 2009, based upon a multinational study of SpA by the Assessment of SpondyloArthritis International Society (ASAS), classifying SpA broadly into two groups [
         <a href="#rid8">
          8,9
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SpA with predominantly axial involvement is designated as "axial spondyloarthritis" (axSpA), which comprises AS (radiographic axial spondyloarthritis), with typical features of sacroiliitis on plain radiography, and axSpA without definite radiographic changes of sacroiliitis. The latter condition is termed "nonradiographic axial spondyloarthritis" (nr-axSpA). The two are probably a continuum of a disease [
         <a href="#rid4">
          4,6,10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Several studies have shown that approximately 10 to 40 percent of patients with nr-axSpA will develop radiographic sacroiliitis of AS within 2 to 10 years [
         <a href="#rid11">
          11
         </a>
         ]. The risk factors for progression are male sex, being positive for human leukocyte antigen (HLA) B27, showing signs of inflammation on MRI of the sacroiliac (SI) joints, having elevated C-reactive protein (CRP), and history of smoking [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SpA with predominantly peripheral involvement is designated as "peripheral SpA," with symptoms mainly of peripheral arthritis, peripheral enthesitis, and/or dactylitis. Axial symptoms may occur but do not have a chronic character. (See
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         All classification criteria, including the 2009/2011 ASAS classification of SpA, the 1984 Modified New York Criteria for AS, the 1990 Amor criteria for SpA, and the 1991 European Spondyloarthritis Study Group (ESSG) criteria for SpA, have been developed for use in research such as epidemiologic studies and therapeutic trials  (
         <a class="graphic graphic_table graphicRef96419" href="/z/d/graphic/96419.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid12">
          12,13
         </a>
         ]. All criteria have disadvantages that limit their use as diagnostic tools in practice. Diagnosis is typically made based upon the clinician's judgment about the combination of symptoms, physical signs, and laboratory and imaging findings present in an individual patient [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14364423">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence
         </strong>
         – The estimates of the prevalence of ankylosing spondylitis (AS) in various countries range from 0.7 to 49 per 10,000 (0.007 to 0.49 percent). The mean prevalences of AS per 10,000 in North America, Europe, Asia, Latin America, and Africa were 31.9, 23.8, 16.7, 10.2, and 7.4, respectively [
         <a href="#rid15">
          15
         </a>
         ]. There is a paucity of information regarding the prevalence of nonradiographic axial spondyloarthritis (nr-axSpA) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The prevalence of AS among working adults with chronic (greater than three months) low back pain was 4.6 percent in one study [
         <a href="#rid16">
          16
         </a>
         ]. In another group with chronic back pain, the prevalence of either AS or undifferentiated spondyloarthritis (SpA) with axial involvement was 5 percent [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/95962.html" rel="external">
          "Overview of the clinical manifestations and classification of spondyloarthritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There is a heterogeneity in the prevalence reported for axSpA because this depends upon the ethnic group studied, the selection of subjects for evaluation, and the criteria for classification. In general, there is a clear correlation between the prevalence of AS in a given population and the prevalence of human leukocyte antigen (HLA) B27 in that group, with the prevalence of AS being approximately 5 to 6 percent among people who are HLA-B27 positive [
         <a href="#rid18">
          18
         </a>
         ]. In the United States, the prevalence of HLA-B27 varies among different ethnic communities; in a 2009 national survey, the prevalence rates of HLA-B27 in non-Hispanic White Americans, Mexican Americans, and non-Hispanic Black Americans were 7.5, 4.6, and 1.1 percent, respectively [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As an example of population data, in the 2009 to 2010 National Health and Nutrition Examination Survey (NHANES) of the general population in the United States, the prevalence of axSpA was 1.4 percent, and the prevalence of AS was 0.55 percent, while the frequency of chronic low back pain in this cohort of 5103 United States adults aged 20 to 69 was 19.4 percent [
         <a href="#rid18">
          18
         </a>
         ]. Similarly, the prevalence of AS in the United States in the 1971 to 1975 NHANES I study of 6913 subjects 25 to 74 years of age was estimated at 0.2 to 0.5 percent [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – The risk of AS is increased among relatives of an affected patient. Reported risks of AS in one report were as follows: monozygotic twins – 63 percent; first-degree relatives – 8.2 percent; second-degree relatives – 1.0 percent; third-degree relatives – 0.7 percent; parent-child – 7.9 percent [
         <a href="#rid21">
          21
         </a>
         ]. Some of these numbers might be overestimates. In general, AS risk is increased approximately 20-fold in parents, siblings, and children of a proband patient with AS. Having more than one relative confers a higher risk [
         <a href="#rid22">
          22
         </a>
         ]. Among siblings, AS occurred almost exclusively among HLA-B27-positive individuals [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         AS is believed to be more common among men, although this may depend on how the disease is identified and defined. The Rochester Epidemiology Project (a population-based cohort of newly diagnosed patients) estimated that the age-adjusted incidence of AS is four times greater in men compared with women (11.7 versus 2.9 per 100,000 person-years) [
         <a href="#rid24">
          24
         </a>
         ]. Similarly, in a meta-analysis of eight studies comprising 2236 patients with AS, 70.4 percent of the patients were male [
         <a href="#rid25">
          25
         </a>
         ]. However, a cohort study of 728,556 United States military personnel indicates that men and women have an approximately equal incidence of AS (26.5 versus 27.2 per 100,000 person-years) [
         <a href="#rid26">
          26
         </a>
         ]. The higher incidence of AS in this study may be partially explained by the use of clinical, rather than radiographic, criteria to diagnose AS.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Sex may not influence the risk of nr-axSpA. The same meta-analysis of eight studies identified 1242 patients with nr-axSpA [
         <a href="#rid25">
          25
         </a>
         ]. In this study, only 46.5 percent of patients with nr-axSpA were male [
         <a href="#rid25">
          25
         </a>
         ]. Male sex has been identified as a risk factor, among others, of radiographic progression in patients with axSpA, which could explain the higher rate of AS among men observed by studies that use radiographic criteria to establish this diagnosis [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          MUSCULOSKELETAL SYMPTOMS AND FINDINGS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Axial spondyloarthritis (axSpA) is characterized by involvement of the spine and sacroiliac (SI) joints, peripheral joints, entheses, and digits, although extraskeletal organs may also be affected. Spinal and SI involvement typically results in inflammatory back pain. The spinal involvement is more extensive in ankylosing spondylitis (AS) and may result in complications, including fracture and neurologic compromise in a very small number of patients (see
         <a class="local">
          'Fractures'
         </a>
         below and
         <a class="local">
          'Neurologic manifestations'
         </a>
         below). The major musculoskeletal features include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SI joints and spinal involvement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hip and shoulder involvement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Peripheral arthritis (in joints other than the hip and shoulder)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Costovertebral, manubriosternal, sternoclavicular, and costochondral inflammation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammation of extraspinal entheses
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dactylitis
        </p>
        <p>
        </p>
        <p>
         The prevalences of peripheral arthritis, enthesitis, and dactylitis vary depending upon the ancestry of the individual [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Low back pain and neck pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Almost all patients with axSpA report back pain, which frequently but not invariably has characteristics suggesting an inflammatory etiology. Several criteria sets are available that define inflammatory back pain, which all perform similarly and can be used in daily practice [
         <a href="#rid29">
          29-31
         </a>
         ]. According to the Assessment of SpondyloArthritis International Society (ASAS) criteria, "inflammatory back pain" typically exhibits at least four of the following five features [
         <a href="#rid29">
          29
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age of onset &lt;40 years
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Insidious onset
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Improvement with exercise
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No improvement with rest
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pain at night (with improvement upon arising)
        </p>
        <p>
        </p>
        <p>
         Other criteria sets for defining inflammatory back pain are the Calin and Berlin criteria, which also include morning stiffness [
         <a href="#rid30">
          30,31
         </a>
         ].
        </p>
        <p>
         Traditionally, back pain that does not fulfill the criteria for inflammatory low back pain is designated as "mechanical low back pain." Neither back pain nor inflammatory back pain is specific for axSpA. In a United States population survey, 19.2 percent of the subjects reported chronic axial pain, with 5 to 6 percent having inflammatory back pain. However, only 0.9 to 1.4 percent of all the subjects in this survey had axSpA [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Neck pain can be a presenting symptom early in the disease and becomes one of the principal problems caused by the disease in nearly one-half of the axSpA patients with established disease and radiographic features [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1931518156">
         <span class="h2">
          Impaired spinal mobility in advanced disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Structural abnormalities of the vertebrae are much more severe in advanced AS compared with nonradiographic axSpA (nr-axSpA) [
         <a href="#rid10">
          10
         </a>
         ]. In AS, the process of progressive spinal fusion may lead to extreme impairment of spinal mobility and also of chest expansion. In a 1948 to 1980 follow-up study of 51 patients, moderate and severe spinal deformity was present at the final year of observation in 15 and 18 percent, respectively; severe restriction of spinal mobility was found in 41 percent [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Examination techniques for assessment of the degree of deformity and for deformities and limitations in spinal mobility as well as chest expansion are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Physical examination'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H542095627">
         <span class="h2">
          Postural abnormalities in advanced disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postural abnormalities, especially hyperkyphosis (hunchback), become apparent as early as within the first 10 years of disease in some AS patients. Hyperkyphosis is caused by wedging of the thoracic vertebrae [
         <a href="#rid35">
          35
         </a>
         ]. The typical stooped posture of an AS patient with advanced disease is caused by a combination of flexion deformity of the neck, thoracic hyperkyphosis, loss of normal lumbar lordosis, and flexion deformities of the hips  (
         <a class="graphic graphic_picture graphicRef55095" href="/z/d/graphic/55095.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid36">
          36
         </a>
         ]. This phenomenon is, however, observed only in a minority of patients.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Buttock pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Buttock pain, especially alternating between the two sides but sometimes only one-sided, may be indicative of SI joint involvement. In a study of 101 patients with AS and 112 with mechanical low back pain, alternating buttock pain was present in 37 percent of patients with AS and only 12 percent of patients with mechanical low back pain [
         <a href="#rid30">
          30
         </a>
         ]. In another study that examined axSpA collectively, the prevalence of alternate buttock pain was 24 percent and discriminated axSpA from other low back pain better than both-sided or one-sided buttock pain [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23851539">
         <span class="h2">
          Hip pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hip involvement, resulting in hip joint pain, is present in approximately 20 to 25 percent of patients with AS, approximately 10 percent of those with nr-axSpA [
         <a href="#rid38">
          38-40
         </a>
         ], and is associated with higher degrees of disability and a worse prognosis. The typical symptom is groin pain, but, as with other disorders of the hip joint, pain may be referred to the medial thigh or even the knee. Flexion deformities of the hips may develop. Hip involvement may be more severe in patients with early onset of AS, axial, and entheseal disease, and such patients may be more likely to eventually require hip replacement surgery [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Peripheral arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Peripheral arthritis is seen in approximately 30 percent of patients with axSpA [
         <a href="#rid25">
          25,28
         </a>
         ]. Joints that may be affected are the ankles, hips, knees, shoulders, and the sternoclavicular joints. Extremely few AS patients voluntarily report temporomandibular joint (TMJ) pain. When specifically evaluated, as many as half of AS patients have at least one TMJ symptom and have some tomographic changes [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Enthesitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The enthesis is the region of attachment of tendons and ligaments to bone; enthesitis, inflammation of the enthesis, is a classic feature of axSpA. Enthesitis manifests as pain, stiffness, and tenderness of insertions, usually without much swelling, although swelling may be a prominent feature at the Achilles tendon attachment  (
         <a class="graphic graphic_picture graphicRef96430" href="/z/d/graphic/96430.html" rel="external">
          picture 2
         </a>
         ). In a meta-analysis of eight studies, the pooled prevalences of a history of enthesitis were 35 percent in nr-axSpA and 29 percent in AS [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Extraspinal areas other than the attachment of Achilles tendon that may be involved by enthesitis in patients with axSpA include the calcaneal attachment of the plantar fascia, the heel, the patellae, the shoulders, the costochondral junctions, the manubriosternal and sternoclavicular joints, and along the superior iliac crest. Tenderness at these and other entheseal sites is suggestive of enthesitis.
        </p>
        <p class="headingAnchor" id="H4760889">
         <span class="h2">
          Dactylitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dactylitis (sausage digits) is characterized by diffuse swelling of toes or fingers  (
         <a class="graphic graphic_picture graphicRef95915 graphicRef96458" href="/z/d/graphic/95915.html" rel="external">
          picture 3A-B
         </a>
         ). A history of dactylitis is present in approximately only 6 percent of patients with AS and a similar proportion of patients with nr-axSpA [
         <a href="#rid3">
          3,28,42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          EXTRAARTICULAR MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In axial spondyloarthritis (axSpA), some coexisting diseases are so strongly associated with the articular disease that they seem to be part of the index disease "SpA" itself. These coexisting diseases, especially acute anterior uveitis, psoriasis, and inflammatory bowel disease (IBD), are therefore referred to as "extraarticular manifestations" (EAMs) rather than being described as comorbidities.
        </p>
        <p>
         Some experts make a distinction between EAMs related to the concept of SpA and EAMs not related to the concept of SpA [
         <a href="#rid43">
          43
         </a>
         ]. EAMs related to the concept of SpA are those that commonly occur in patients with axSpA (typically in 10 to 50 percent of patients), involve clinically evident inflammation, and can occur at any point during disease evolution. Sometimes the activity of the EAM may fluctuate with the axial or peripheral joint symptoms. Acute anterior uveitis, psoriasis, and IBD are conditions considered SpA-related EAMs.
        </p>
        <p>
         EAMs that are not considered related to the concept of SpA are rare (1 percent of patients) compared with related EAMs, are typically subclinical, occur in patients with longstanding disease, and are unrelated to the activity of joint or spine symptoms [
         <a href="#rid43">
          43
         </a>
         ]. Conditions frequently considered as non-SpA-related EAMs are those affecting the heart, kidneys, and lungs.
        </p>
        <p>
         Besides EAMs, comorbidities of the disease may also occur, for example, cardiovascular disease related to longstanding inflammation.
        </p>
        <p>
         Patients with axSpA also complain of constitutional symptoms. In particular, fatigue is a common problem in axSpA [
         <a href="#rid44">
          44,45
         </a>
         ]. Poor sleep is common and is thought to be related in part to pain caused by active disease.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Acute anterior uveitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unilateral uveitis is a common EAM of both ankylosing spondylitis (AS) and nonradiographic axSpA (nr-axSpA) [
         <a href="#rid25">
          25,46-48
         </a>
         ]. The frequency of uveitis in patients with SpA is approximately 25 to 35 percent, but accurate estimates are difficult because the occurrence of uveitis is associated with longer disease duration and the presence of human leukocyte antigen (HLA)-B27 [
         <a href="#rid48">
          48,49
         </a>
         ]. The incidence rate is over 20 times greater in patients compared with population-based controls (8.9 versus 0.42 per 1000 patient-years) [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         Uveitis typically presents as acute unilateral pain, photophobia, and blurring of vision [
         <a href="#rid50">
          50
         </a>
         ]. Uveitis may be the first problem to require medical evaluation and should alert clinicians to the possibility of SpA. Approximately 50 percent of patients with acute recurrent unilateral anterior uveitis have a form of SpA [
         <a href="#rid51">
          51
         </a>
         ]. The activity and severity of the eye disease are not correlated with the activity and severity of the articular disease.
        </p>
        <p>
         Recurrence is common despite the effectiveness of local therapy but seldom leads to permanent impairment of vision. In one study of 148 patients with HLA-B27-associated uveitis performed before the availability of tumor necrosis factor (TNF) inhibitors, the median duration of an attack was six weeks, and there were a median number of three recurrences for patients with more than 12 months of follow-up [
         <a href="#rid52">
          52
         </a>
         ]. Cataracts and glaucoma can also occur. They are associated with posterior synechiae, increased intraocular pressure, and cystoid macular edema. The evaluation and management of uveitis are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5581.html" rel="external">
          "Uveitis: Etiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5592.html" rel="external">
          "Uveitis: Treatment", section on 'Noninfectious uveitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H360346184">
         <span class="h2">
          Inflammatory bowel disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ileal and colonic mucosal inflammation, which are frequently asymptomatic, can be detected by histologic examination in approximately 50 percent of patients with nr-axSpA and AS [
         <a href="#rid53">
          53-55
         </a>
         ]. A minority of those with histologic inflammation develop clinically apparent IBD, whether Crohn disease or ulcerative colitis, with overt IBD found in approximately 6.4 percent of patients with nr-axSpA and 4.1 percent of those with AS [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         On the other hand, back and joint pain is common in patients with IBD, and at least one-third of patients with IBD show some features of SpA, including axSpA and peripheral SpA with changes in the sacroiliac joints visible on imaging [
         <a href="#rid56">
          56-59
         </a>
         ]. However, in a prospective study only 10 percent of the IBD patients with chronic back pain or peripheral joint complaints eventually received a diagnosis of SpA from a rheumatologist [
         <a href="#rid60">
          60
         </a>
         ]. The association between HLA-B27 and AS is weaker in the presence of established IBD, compared with AS [
         <a href="#rid61">
          61
         </a>
         ]. However, the clinical presentation is very similar.
        </p>
        <p>
         Peripheral and axial arthritis associated with IBD is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">
          "Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H360346250">
         <span class="h2">
          Psoriasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Psoriasis is present in up to approximately 10 percent of patients with nr-axSpA and AS [
         <a href="#rid25">
          25,48,62
         </a>
         ]. Patients with concomitant psoriasis have more frequent peripheral joint involvement and possibly a more severe axSpA disease course compared with axSpA patients without psoriasis [
         <a href="#rid63">
          63,64
         </a>
         ]. Similar to IBD, the association between HLA-B27 and AS is weaker in the presence of established psoriasis compared with AS alone [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         Peripheral and axial arthritis associated with psoriasis (psoriatic arthritis) is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3547546280">
         <span class="h1">
          SEX DIFFERENCES IN DISEASE PATTERN
         </span>
         <span class="headingEndMark">
          —
         </span>
         Increasingly, studies have shown that axial spondyloarthritis (axSpA) runs a different disease course in women compared with men [
         <a href="#rid65">
          65
         </a>
         ]. In women, more cervical involvement of the spine and more peripheral involvement (arthritis, enthesitis, dactylitis) is seen, and women have a higher prevalence of inflammatory bowel disease (IBD) and psoriasis. In contrast to men, women tend to have less structural damage in the sacroiliac (SI) joint and spine. Additionally, progression of radiographic abnormalities is greater in men. Men experience more limitations in chest expansion and thoracic kyphosis. Inflammatory back pain is more often reported by men as a first symptom of axSpA.
        </p>
        <p class="headingAnchor" id="H730507630">
         <span class="h1">
          COMORBIDITIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the prevalences of comorbidities are higher in those patients with axial spondyloarthritis (axSpA) who have higher disease activity and functional impairment, more severe pain, and poorer quality of life [
         <a href="#rid66">
          66
         </a>
         ]. In addition to the major comorbidities described here, including osteopenia, poor psychosocial status, cardiovascular disease, and pulmonary disease, other less common comorbidities have also been described [
         <a href="#rid67">
          67
         </a>
         ]. (See
         <a class="local">
          'Osteopenia'
         </a>
         below and
         <a class="local">
          'Psychosocial status'
         </a>
         below and
         <a class="local">
          'Cardiovascular disease'
         </a>
         below and
         <a class="local">
          'Pulmonary disease'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1995915111">
         <span class="h2">
          Osteopenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Osteoporosis and reduced bone mass are common in patients with spondyloarthritis (SpA), even in young males with short disease duration [
         <a href="#rid68">
          68
         </a>
         ]. Low bone mineral density (BMD) and bone loss are evident within the first 10 years of disease [
         <a href="#rid69">
          69-71
         </a>
         ], and, in more than half of patients with longstanding and persistently active disease, BMD is decreased at both the spine and the hip [
         <a href="#rid72">
          72,73
         </a>
         ]. In a multinational study of 3984 patients with SpA, osteoporosis was the most common comorbidity identified (13 percent) [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         However, with advanced ankylosing spondylitis (AS), dual photon absorptiometry (DEXA) measurement of BMD of the spine may provide falsely high values because of the superimposed effect of syndesmophytes and periosteal bone formation [
         <a href="#rid75">
          75
         </a>
         ]. However, estimation of bone density in the presence of syndesmophytes may be facilitated by dual-energy quantitative computed tomography (CT) scanning of the spine; using this technique, it has been shown that patients with syndesmophytes have lower bone mass than those without this finding [
         <a href="#rid76">
          76
         </a>
         ]. Osteopenia or frank osteoporosis may predispose to fracture, especially in the spine. (See
         <a class="local">
          'Fractures'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H10175594">
         <span class="h2">
          Psychosocial status
         </span>
         <span class="headingEndMark">
          —
         </span>
         AxSpA can adversely affect psychologic health and socioeconomic status in addition to causing pain and disability. Taken together, these factors influence the patient's overall quality of life, and they are collectively responsible for the intensity of pain, fatigue, and sleep disturbance [
         <a href="#rid77">
          77-80
         </a>
         ]. A sense of helplessness (a feeling of an inability to actively cope with the disease) was an important contextual factor identified in both longitudinal and cross-sectional studies that affected health-related quality of life and functional measures [
         <a href="#rid81">
          81-83
         </a>
         ]. A 2020 meta-analysis of four studies indicates that the odds ratio (OR) of depression in is almost twice as likely in patients with axSpA compared with controls (pooled OR of 1.8) [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         In small studies, symptoms of pain and fatigue in patients with AS were associated on MRI and on functional MRI with structural differences in certain regions in white and gray matter of the brain, compared with controls, as well as abnormal cross-network functional connectivity [
         <a href="#rid84">
          84-86
         </a>
         ]. A 2020 systematic literature review showed that overall one in six patients with axSpA satisfy the criteria for fibromyalgia [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21153910">
         <span class="h2">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         AS is associated with an increased risk of cardiovascular diseases, including hypertension, heart failure, acute coronary syndromes (ACS), strokes, venous thromboembolism, conduction abnormalities, and, rarely, disease of the aortic root and of the aortic valve. Although cardiovascular involvement has been examined in patients with AS in several studies [
         <a href="#rid88">
          88-90
         </a>
         ] and evaluated in patients with SpA in general [
         <a href="#rid66">
          66,74
         </a>
         ], it has not been examined specifically in patients with nr-axSpA.
        </p>
        <p>
         The estimated frequencies of aortic regurgitation and conduction disturbances are both increased but vary considerably, ranging from 6 to 10 percent for aortic regurgitation and from 3 to 33 percent for conduction disturbances [
         <a href="#rid91">
          91-95
         </a>
         ]. In patients with AS, even without clinical evidence of heart disease, the aortic roots are less elastic than in healthy controls, based upon measurement of aortic distensibility [
         <a href="#rid96">
          96
         </a>
         ]. This probably reflects a sclerosing inflammatory process involving the aortic root (aortitis), the aortic valve cusps, and the interventricular septum. The ultimate consequences are cusp retraction, aortic regurgitation, and conduction abnormalities [
         <a href="#rid95">
          95,96
         </a>
         ].
        </p>
        <p>
         Most but not all studies show increases in ischemic heart disease compared with the general population. The increased risk has been attributed to the systemic inflammation and increased prevalence of traditional cardiovascular risk factors. Differences between studies may reflect the particular populations studied and both differences and flaws in study design [
         <a href="#rid88">
          88-90
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21153916">
         <span class="h2">
          Pulmonary disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a minority of AS patients after longstanding disease, pulmonary compromise occurs due to restrictive changes caused by the musculoskeletal disease and changes in the lungs themselves, including interstitial, nodular, and parenchymal abnormalities [
         <a href="#rid97">
          97
         </a>
         ]. Pulmonary involvement has been studied in patients with AS but not examined in nr-axSpA. (See
         <a class="medical medical_review" href="/z/d/html/4320.html" rel="external">
          "Chest wall diseases and restrictive physiology", section on 'Ankylosing spondylitis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Restrictive pulmonary disease is related largely to diminished chest wall and spinal mobility. In one study in which pulmonary function tests (PFTs) were compared between patients with AS and matched controls, 18 percent of patients with AS but none of the controls showed a restrictive pattern [
         <a href="#rid98">
          98
         </a>
         ]. Vital capacity was decreased and functional residual capacity was increased in AS.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A small percentage of AS patients, with estimates ranging from 1.3 to 15 percent, have evidence of other pulmonary changes such as apical pulmonary fibrosis by plain radiography [
         <a href="#rid99">
          99-102
         </a>
         ]. The apical fibrosis is usually asymptomatic and associated with a long duration of disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormalities in AS detected on a high-resolution CT are much more common than findings on plain radiography. These include a mosaic pattern, subpleural nodules, and parenchymal bands and may be present even early in the disease [
         <a href="#rid101">
          101,102
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fibrotic disease and cigarette smoking may be risk factors for spontaneous pneumothorax, a complication that is otherwise rare in AS [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The causes of these intrinsic pulmonary abnormalities are unknown. There is a lack of evidence for alveolitis, as bronchoalveolar lavage is generally unremarkable [
         <a href="#rid100">
          100
         </a>
         ]. However, in one report, transbronchial biopsies revealed interstitial fibrosis of variable degree in 5 out of 12 patients, indicating that the radiologic appearance of apical fibrosis may actually reflect a more generalized process [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H360346282">
         <span class="h1">
          COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H360346583">
         <span class="h2">
          Fractures
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vertebral fractures
         </strong>
         – Vertebral fragility fractures from trauma are at least twice as common in ankylosing spondylitis (AS) compared with non-AS controls [
         <a href="#rid104">
          104,105
         </a>
         ]. Estimates of the lifetime incidence of clinical vertebral fracture in patients with AS range from 4 to 18 percent [
         <a href="#rid106">
          106
         </a>
         ]. Patients with ankylosed spines can develop vertebral fractures with minimal (and sometimes not recollected) trauma [
         <a href="#rid107">
          107,108
         </a>
         ]. The increased risk of vertebral fracture is thought to be due to a combination of low bone mineral density (BMD) and spinal rigidity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The lower cervical spine is the most commonly involved area. Of the three major types of fracture (extension, flexion, and compression), the one most common in AS is an extension fracture [
         <a href="#rid109">
          109
         </a>
         ]. CT and MRI are more sensitive and specific techniques for detecting these fractures than plain radiography, which may appear normal despite the presence of a fracture  (
         <a class="graphic graphic_diagnosticimage graphicRef94271" href="/z/d/graphic/94271.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid110">
          110
         </a>
         ]. Additionally, hyperkyphosis of the spine is common in patients with longstanding AS, and many of these patients have anterior wedging of the thoracic vertebrae as well as the intervertebral discs [
         <a href="#rid35">
          35,111
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Non-vertebral fractures
         </strong>
         – Whether AS is also associated with an increased risk of non-vertebral fractures is less clear. In a study of 758 patients with AS, the risk of hip and forearm fractures was not significantly increased (odds ratio [OR] 0.77 and 1.21, respectively) [
         <a href="#rid104">
          104
         </a>
         ]. However, a larger study of 5909 patients with AS indicated that AS was associated with hip fractures (adjusted hazard ratio 1.65). This larger study also demonstrated that patients with AS developed hip fractures at a younger age than matched non-AS controls (74 versus 79 years) [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Neurologic manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         In AS, neurologic symptoms can occur by several different mechanisms, including cord or spinal nerve compression due to fracture of the ankylosed spine or from atlantoaxial subluxation. Delayed diagnosis of fracture is not uncommon because most injuries are from only minor low-energy trauma, and sustained neurologic deficits are common [
         <a href="#rid113">
          113
         </a>
         ]. Additionally, and unrelated to spinal fractures, subclinical neuropathy, myelopathy, and myopathy are common but rarely symptomatic [
         <a href="#rid114">
          114
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Spinal cord injury
         </strong>
         – Spinal cord injury is 11 times more common in AS than in the general population and affects the cervical spine, including the lower cervical spine, more often than the thoracic and lumbar spine [
         <a href="#rid115">
          115
         </a>
         ]. Approximately 50 to 65 percent of spinal fractures are associated with neurologic complications, although the initial complaints are often subtle and might be missed without a high index of suspicion [
         <a href="#rid113">
          113,116
         </a>
         ]. The morbidity of spinal injury is very high, causing paraparesis or tetraparesis in some patients [
         <a href="#rid106">
          106
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atlantoaxial subluxation
         </strong>
         – Clinically significant spontaneous subluxation of the atlantoaxial joint (C1-C2) may occur in patients with AS; it can lead to spinal cord compression if it is not recognized and stabilized. As an example, in one study of 103 patients, anterior or posterior atlantoaxial subluxation was observed in 21 and 2 percent of individuals, respectively [
         <a href="#rid117">
          117,118
         </a>
         ]. In a two-year follow-up, progression of anterior subluxation was observed in approximately 50 percent. In other reports, clinically significant spontaneous subluxation occurred in approximately 2 percent of individuals. This problem is managed in a fashion similar to that in rheumatoid arthritis (RA). (See
         <a class="medical medical_review" href="/z/d/html/7518.html" rel="external">
          "Cervical subluxation in rheumatoid arthritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cauda equina syndrome
         </strong>
         – The cauda equina syndrome is a rare complication in patients with AS, typically reported in patients with longstanding disease who have marked ankylosis of the spine [
         <a href="#rid106">
          106,119,120
         </a>
         ]. The symptoms are those of damage to the lumbosacral nerve roots, probably caused by arachnoiditis. Patients usually complain of abnormalities in cutaneous sensation, problems with bladder and bowel control, and impotence. (See
         <a class="medical medical_review" href="/z/d/html/2819.html" rel="external">
          "Clinical features and diagnosis of neoplastic epidural spinal cord compression", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Renal disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal disease is very uncommon in axial spondyloarthritis (axSpA), but nonspecific glomerulopathy, immunoglobulin A (IgA) nephropathy, and renal amyloidosis may be seen in AS [
         <a href="#rid121">
          121-123
         </a>
         ]. In a cohort of 681 patients diagnosed with AS in 2008/2009, abnormal findings on urinalysis were seen in 8 percent, including proteinuria and/or hematuria. Patients with proteinuria exceeding 1000 mg per day underwent renal biopsy. The biopsies showed nonspecific glomerulopathy (three patients), IgA nephropathy (two patients), and amyloidosis (one patient) [
         <a href="#rid121">
          121
         </a>
         ]. This spectrum of renal diseases is in agreement with an earlier literature review [
         <a href="#rid122">
          122
         </a>
         ]. Renal amyloidosis is rare [
         <a href="#rid121">
          121,124,125
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7175.html" rel="external">
          "Clinical manifestations and diagnosis of analgesic nephropathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3112.html" rel="external">
          "IgA nephropathy: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3120.html" rel="external">
          "Renal amyloidosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4084459435">
         <span class="h2">
          Pregnancy outcomes
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are conflicting data regarding the impact of axSpA on pregnancy outcomes. A review of 21 studies assessing pregnancy and AS demonstrated an increased risk of prematurity (OR 1.99, 95% CI 1.30-3.05) and small-for-gestational-age births (OR 2.41, 95% CI 1.22-4.77) for pregnancies in patients with AS [
         <a href="#rid126">
          126
         </a>
         ]. Similarly, a retrospective analysis of 2479 women enrolled in The Danish Medical Birth Registry with a diagnosis of spondyloarthritis (SpA) between 1997 and 2016 also demonstrated that women with SpA carried a higher chance of preterm birth and elective cesarean delivery [
         <a href="#rid127">
          127
         </a>
         ].
        </p>
        <p>
         More optimistic results were demonstrated by a nationwide cohort study in Sweden, which examined the outcomes of 1580 births in women with axSpA between 2007 and 2020 [
         <a href="#rid128">
          128,129
         </a>
         ]. In this study, axSpA was not associated with an increased risk preterm birth, preeclampsia, elective cesarean delivery, or serious infant infection. During the 13-year study period, the risks of preterm birth, infant infection, and cesarean delivery decreased by 0.5 percent annually.
        </p>
        <p>
         Similarly, the European Network of Pregnancy Registries in Rheumatology, which evaluated pregnancy outcomes in 304 females with axSpA starting in 2015, also suggests that the risk of pregnancy complications is comparable among women with axSpA versus the general population [
         <a href="#rid130">
          130
         </a>
         ]. In this study, the rates of preeclampsia, preterm birth, and low birth weight were either comparable or less than in the general European population. Preconception counseling, tight management of pregnancies, and a tailored treatment approach may have contributed to these good outcomes.
        </p>
        <p>
         Whether these improved outcomes can be attributed to more widespread use of tumor necrosis factor (TNF) inhibitors is not clear. In the Swedish cohort study, the use of TNF inhibitors increased from 10 to 40 percent over the study period; in the European registry study, 67 percent of women did not receive TNF inhibitors during pregnancy.
        </p>
        <p>
         Only limited data examine the impact of pregnancy on disease activity in patients with axSpA. In the review cited above, it was found that 25 to 80 percent of patients experienced a disease flare during pregnancy, and 30 to 100 percent experienced a disease flare after delivery [
         <a href="#rid126">
          126
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23851690">
         <span class="h1">
          LABORATORY FINDINGS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory findings in axial spondyloarthritis (axSpA) are generally nonspecific. An elevated acute phase response may be present, including an elevated erythrocyte sedimentation rate (ESR) and elevated C-reactive protein (CRP), in approximately 50 to 70 percent of patients with active ankylosing spondylitis (AS), but such changes are less frequent in patients with nonradiographic axSpA (nr-axSpA) at approximately 30 percent [
         <a href="#rid131">
          131
         </a>
         ]. Thus, a normal ESR and CRP do not exclude axSpA [
         <a href="#rid3">
          3,42,132
         </a>
         ]. A normochromic normocytic anemia is occasionally seen, most typically in patients with very active disease [
         <a href="#rid132">
          132,133
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7483.html" rel="external">
          "Acute phase reactants"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7149.html" rel="external">
          "Anemia of chronic disease/anemia of inflammation"
         </a>
         .)
        </p>
        <p>
         The level of serum bone-specific alkaline phosphatase may be elevated in severe axSpA [
         <a href="#rid134">
          134
         </a>
         ]; one study found that mildly elevated serum alkaline phosphatase levels were present in 13 percent of patients with axSpA and associated with high disease activity, greater structural damage in the sacroiliac (SI) joints and spine, and lower bone mineral density (BMD) [
         <a href="#rid135">
          135
         </a>
         ]. Serum levels of IgA are also commonly elevated above the normal range [
         <a href="#rid136">
          136,137
         </a>
         ].
        </p>
        <p>
         Synovial fluid findings are typical of inflammatory arthritis, with an increased white blood cell count that is dominated by polymorphonuclear leukocytes. (See
         <a class="medical medical_review" href="/z/d/html/1828.html" rel="external">
          "Synovial fluid analysis"
         </a>
         .)
        </p>
        <p>
         Human leukocyte antigen (HLA) B27 is present, but not invariably so, in most patients with axSpA. In a pooled analysis of eight cohorts (from seven European countries and Turkey), the prevalences of HLA-B27 in nr-axSpA and AS were 77 and 78 percent, respectively [
         <a href="#rid25">
          25
         </a>
         ]. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H13068279">
         <span class="h1">
          MUSCULOSKELETAL IMAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of imaging abnormalities, particularly those affecting the sacroiliac (SI) joints and spine, are characteristic of axial spondyloarthritis (axSpA), including changes that may be evident on conventional radiographs and by MRI. Such findings are reviewed here, while the selection of diagnostic imaging studies and the utility of particular studies and findings for the diagnosis of axSpA are presented in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Imaging studies'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4194880">
         <span class="h2">
          Sacroiliac joints and pelvis
         </span>
         <span class="headingEndMark">
          —
         </span>
         An abnormal appearance of the SI joint(s) using an appropriate imaging technique is a hallmark of axSpA. Definite changes on radiography are characteristic of ankylosing spondylitis (AS), while patients with nonradiographic axSpA (nr-axSpA) by definition exhibit normal or minimally abnormal radiography of the SI joints but may have abnormal MRI findings of the joints that support the diagnosis of axSpA.
        </p>
        <p>
         Radiographic findings of the SI joints range from subtle joint-space narrowing and sclerosis to erosive change and may eventually result in bony ankylosis (fusion). Radiography and MRI are the principal techniques used to assess the SI joints; additional methods that have been used to detect abnormalities include CT and scintigraphy. CT, especially low-dose CT, can demonstrate erosions in some patients in whom the radiographic findings are uncertain. Scintigraphy can show abnormal increased uptake, but such findings are not specific for sacroiliitis.
        </p>
        <p class="headingAnchor" id="H3513790291">
         <span class="h3">
          Radiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Plain radiographic findings of axSpA can be recognized on a standard anteroposterior (AP) plain radiograph of the pelvis; the SI joint abnormalities can include erosions, ankylosis, changes in joint width, or sclerosis. In the first few years of axSpA, the radiographic changes in the SI joints can be quite subtle, but up to approximately 20 to 30 percent of patients may exhibit some abnormalities on SI joint radiographs [
         <a href="#rid138">
          138-141
         </a>
         ].
        </p>
        <p>
         Normal SI joints have well-defined thin white subchondral bony margins. In AS, erosions begin on the iliac side of the SI joint where cartilage is thinner than on the sacral side. SI joint abnormalities can include erosions (with loss of the white line), ankylosis, changes in joint width, and sclerosis [
         <a href="#rid138">
          138
         </a>
         ]. As disease becomes more advanced the most obvious abnormalities are fusion and large erosions. Larger erosions are seen as irregular bony margins, usually associated with widening of the joint space. In advanced disease of the joint, when an SI joint is fused, the joint space disappears, so that the bone is continuous between the sacrum and the ilium. On the radiograph, the joint space becomes a thin, narrow line. In nr-axSpA, the radiographic appearances of the sacroiliac joints are normal or suspicious (but not definite).
        </p>
        <p>
         The SI joint abnormalities are typically graded from 0 (normal) to 4 (total ankylosis) to identify the nature and severity of involvement, and such grading is used to determine the degree of confidence that the changes seen reflect sacroiliitis [
         <a href="#rid142">
          142-144
         </a>
         ]. The level of change that defines AS that is employed in the modified New York criteria used for inclusion in clinical trials requires bilateral grade 2 or unilateral grade 3 changes. Minor abnormalities can be seen on plain radiographs in patients with nr-axSpA. The findings that characterize each grade are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 0: Normal  (
         <a class="graphic graphic_diagnosticimage graphicRef63078" href="/z/d/graphic/63078.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef123077" href="/z/d/graphic/123077.html" rel="external">
          image 3
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 1: Suspicious (but not definite) changes  (
         <a class="graphic graphic_diagnosticimage graphicRef96418" href="/z/d/graphic/96418.html" rel="external">
          image 4
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 2: Minimal abnormality – Small localized areas with erosions or sclerosis, without alteration in the joint width  (
         <a class="graphic graphic_diagnosticimage graphicRef123079 graphicRef123080" href="/z/d/graphic/123079.html" rel="external">
          image 5A-B
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 3: Unequivocal abnormality – Moderate or advanced sacroiliitis with one or more of the following: erosions, sclerosis, joint-space widening, narrowing, or partial ankylosis  (
         <a class="graphic graphic_diagnosticimage graphicRef68009 graphicRef79174" href="/z/d/graphic/68009.html" rel="external">
          image 6A-B
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef123080" href="/z/d/graphic/123080.html" rel="external">
          image 5B
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 4: Total ankylosis of joints  (
         <a class="graphic graphic_diagnosticimage graphicRef58791 graphicRef70511" href="/z/d/graphic/58791.html" rel="external">
          image 7A-B
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         A number of publications have reviewed and given illustrations of the imaging features of normal and abnormal sacroiliac joints [
         <a href="#rid145">
          145
         </a>
         ]. Other examples of the various grades are available in the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.asas-group.org%2Feducation%2Fasas-slide-library%2F&amp;token=j%2BtF41plvYHq0KcVLVNCghGDsEJT6i1q8ZU1boo9WL%2B34DCZ514U%2BErKXWpe3BHX3P5nIfgNbc1c%2Bm9ug%2B3DKQ%3D%3D&amp;TOPIC_ID=7785" target="_blank">
          slide library
         </a>
         of the Assessment of SpondyloArthritis International Society (ASAS). Scoring of the grades is reader-dependent to some degree [
         <a href="#rid144">
          144
         </a>
         ]. Hence, scoring of the same SI joint might vary between readers, especially with grades 0, 1, and 2.
        </p>
        <p>
         The use of sacroiliac joint grading for the identification of sacroiliitis and the diagnosis of axSpA is described in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">
          "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Plain radiography'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2150320500">
         <span class="h3">
          MRI of sacroiliac joints
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRI, unlike radiography, can reveal inflammatory changes, fatty changes, and subtle structural abnormalities. Such findings are especially important in nr-axSpA because the radiographs in nr-axSpA, by definition, are normal or equivocal. However, not all patients with nr-axSpA have abnormal MRI findings, and false-positive findings may occur in healthy individuals without axSpA [
         <a href="#rid146">
          146
         </a>
         ].
        </p>
        <p>
         Findings of active sacroiliitis, which are usually evident without contrast enhancement and best seen on semicoronal views parallel to the long axes of the SI joints, have been defined by the ASAS [
         <a href="#rid147">
          147,148
         </a>
         ]; they include active inflammatory lesions of the SI joints, which appear as "bone marrow edema" (BME) on short tau inversion recovery (STIR) or on T2-weighted images with fat suppression. Typical locations of BME in patients with axSpA include subchondral or periarticular bone marrow  (
         <a class="graphic graphic_diagnosticimage graphicRef74986" href="/z/d/graphic/74986.html" rel="external">
          image 8
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef58047" href="/z/d/graphic/58047.html" rel="external">
          image 9
         </a>
         ). The lesions are of high intensity on T2 and give a dark signal in the T1-weighted images. Similar lesions appearing as bright signals on T1-weighted images after gadolinium contrast administration are referred to as "osteitis” and are considered equivalent. However, MRI contrast use is not required for evaluation of the SI joints in patients with suspected axial SpA. It is rare for MRI of definite sacroiliitis to show only one lesion.
        </p>
        <p>
         BME in the SI joints is not entirely axSpA-specific. The presence of BME on MRI, even of high intensity, has been observed in up to 23 percent of patients with mechanical back pain and 7 percent of healthy volunteers [
         <a href="#rid149">
          149-152
         </a>
         ].
        </p>
        <p>
         Structural abnormalities (eg, erosions, bony ankylosis, fat metaplasia, or sclerosis)  (
         <a class="graphic graphic_diagnosticimage graphicRef104064" href="/z/d/graphic/104064.html" rel="external">
          image 10
         </a>
         ) may also be seen but can be nonspecific as well, as are other inflammatory lesions such as synovitis, enthesitis, or capsulitis, which may also be present [
         <a href="#rid153">
          153,154
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1762716339">
         <span class="h3">
          CT of the sacroiliac joints
         </span>
         <span class="headingEndMark">
          —
         </span>
         High-resolution CT scans can demonstrate structural changes of the SI joints, such as erosion, more clearly than plain radiograph [
         <a href="#rid155">
          155
         </a>
         ]. Hence, CT is more sensitive than radiography for detecting erosion [
         <a href="#rid156">
          156
         </a>
         ]. CT is not generally recommended to establish the diagnosis of sacroiliitis. There is no standardization as yet as to the equipment or interpretations applicable to SpA. However, it may be useful in clinical practice if radiographs are ambiguous and especially if structural changes are suspected or if MRI cannot be performed [
         <a href="#rid157">
          157
         </a>
         ]. If a CT is considered, a low-radiation CT of the SI joint should be ordered, which is normally sufficient [
         <a href="#rid156">
          156
         </a>
         ]. Limitations of CT include the inability to assess the activity of inflammation.
        </p>
        <p class="headingAnchor" id="H190811149">
         <span class="h3">
          Radiographic progression of sacroiliitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several studies have explored the rates and predictors of radiographic progression in SI joints in SpA [
         <a href="#rid11">
          11
         </a>
         ]. Studies involving patients fulfilling the ASAS criteria showed a progression from nr-axSpA to AS of approximately 1 to 5 percent per year. A positive MRI for active sacroiliitis, human leukocyte antigen (HLA) B27 positivity, smoking, male sex, and an elevated C-reactive protein (CRP) were important predictors for progression. Sequential studies of either plain radiographs or MRI are not used in clinical practice, although they have been performed for research purposes.
        </p>
        <p class="headingAnchor" id="H13068297">
         <span class="h2">
          Spine
         </span>
        </p>
        <p class="headingAnchor" id="H2242137560">
         <span class="h3">
          Radiography of the spine
         </span>
         <span class="headingEndMark">
          —
         </span>
         A series of plain (conventional) radiographic changes characteristic of AS can develop progressively over the course of disease; these are best seen on the lateral view [
         <a href="#rid139">
          139
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Squaring of the vertebral bodies due to anterior and posterior inflammation and bone erosion and deposition is a relatively early radiographic sign of spinal involvement in AS  (
         <a class="graphic graphic_diagnosticimage graphicRef64101" href="/z/d/graphic/64101.html" rel="external">
          image 11
         </a>
         ) [
         <a href="#rid158">
          158
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Changes that are more easily distinguished and found at later stages of AS include syndesmophytes and ankylosis of the facet joints  (
         <a class="graphic graphic_diagnosticimage graphicRef69803" href="/z/d/graphic/69803.html" rel="external">
          image 12
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef93364" href="/z/d/graphic/93364.html" rel="external">
          image 13
         </a>
         ). When syndesmophytes from a lower and an upper vertebra join together, they become a bridge. Syndesmophytes may very infrequently (fewer than 5 percent) be present in the absence of radiographic sacroiliitis [
         <a href="#rid159">
          159
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The signature abnormality that is most easily recognizable is the bamboo spine in late AS  (
         <a class="graphic graphic_diagnosticimage graphicRef74920" href="/z/d/graphic/74920.html" rel="external">
          image 14
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         Unlike in AS, syndesmophytes of the spine are rare in patients with nr-axSpA [
         <a href="#rid160">
          160
         </a>
         ].
        </p>
        <p>
         Anterior atlantoaxial (C1-C2) subluxation of can also be visualized by use of radiographs; lateral views in flexion and extension may be necessary to demonstrate subluxation and whether or not it reduces in extension (see
         <a class="local">
          'Neurologic manifestations'
         </a>
         above). This finding has been reported in 14.1 percent of a cohort of 819 patients with AS [
         <a href="#rid118">
          118
         </a>
         ]. Other findings of AS that may be apparent on radiographs of the spine are discovertebral (Andersson) lesions and acute fractures [
         <a href="#rid161">
          161
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1597520047">
         <span class="h3">
          MRI of the spine
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRI of the lumbar spine may show changes other than those visible on plain radiographs and infrequently even in the absence of SI joint inflammation [
         <a href="#rid8">
          8
         </a>
         ]; spinal changes in the absence of significant SI joint inflammation were more frequent in a study population of patients with clinically active, longstanding nr-axSpA [
         <a href="#rid162">
          162
         </a>
         ]. The spinal lesions of anterior/posterior spondylitis appear either as BME (bright signal on STIR or T2-weighted sequences with fat suppression) or areas of fatty deposition (bright signal in T1-weighted sequences)  (
         <a class="graphic graphic_diagnosticimage graphicRef96351" href="/z/d/graphic/96351.html" rel="external">
          image 15
         </a>
         ) [
         <a href="#rid163">
          163
         </a>
         ]. These lesions commonly localize to the anterior or posterior vertebral corners on sagittal views of the spine but can also be found in posterior vertebral elements. The finding of a single or only a few vertebral lesions is relatively nonspecific [
         <a href="#rid153">
          153
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2002590592">
         <span class="h3">
          Radiographic progression of spinal changes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Radiographic involvement of the vertebrae is much more prominent in AS compared with nr-axSpA [
         <a href="#rid10">
          10
         </a>
         ]. The endpoint of radiographic progression of the AS spine is total fusion in the form of a "bamboo spine." The evolution of these changes has been described in a prospective longitudinal study of 211 Western European AS patients followed over 12 years [
         <a href="#rid164">
          164,165
         </a>
         ]. The initial radiographic abnormalities were erosions and sclerosis at vertebral corners. These were followed by the appearance of syndesmophytes. Bridging of syndesmophytes across vertebrae led to fusion  (
         <a class="graphic graphic_diagnosticimage graphicRef101808" href="/z/d/graphic/101808.html" rel="external">
          image 16
         </a>
         ). Taking all patients together, there was a linear overall progression of these changes over time. However, there was a great deal of variability among patients. Over the period of 12 years, approximately a quarter of the patients did not show any progression. By contrast, another quarter showed clinically important progression, such as having multiple new erosions, squaring or sclerosis, or new syndesmophytes over two years. One-half of the patients fell between these extremes, having one or a few new erosions, squaring or sclerosis, or up to two new syndesmophytes over two years. The factors that correlated with faster progression were male sex, preexisting radiographic damage, positive testing for HLA-B27, and a history of smoking.
        </p>
        <p>
         The endpoint of spinal fusion was evaluated in a separate study of 769 United States patients, which found complete spinal fusion in 28 percent of patients with AS for more than 30 years and 43 percent of those with AS for more than 40 years [
         <a href="#rid139">
          139
         </a>
         ].
        </p>
        <p>
         Radiographic changes in the lumbar spine are associated with functional impairment in the second and third decades of disease. Functional impairment in the third and fourth decades is associated with cervical spine changes. By the fifth decade, comorbid conditions usually associated with that age group become more important than radiographic changes [
         <a href="#rid166">
          166
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1978332913">
         <span class="h2">
          Hips
         </span>
         <span class="headingEndMark">
          —
         </span>
         Radiographic involvement of the hip is sometimes observed in patients with AS and may result in a destructive joint changes  (
         <a class="graphic graphic_diagnosticimage graphicRef79002" href="/z/d/graphic/79002.html" rel="external">
          image 17
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef96511" href="/z/d/graphic/96511.html" rel="external">
          image 18
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef96524" href="/z/d/graphic/96524.html" rel="external">
          image 19
         </a>
         ). Characteristic features of hip involvement in AS include circumferential cartilage space narrowing, axial migration of the femoral head, protrusion deformity, and a ring of osteophytes [
         <a href="#rid167">
          167
         </a>
         ]. Additional changes typical but not diagnostic of AS that may also be seen on radiography of the pelvis include erosions and osteitis at the ischial tuberosities, iliac crests, symphysis pubis, femoral trochanters, and hips. Radiographs from these sites typically show destructive changes without much new bone formation [
         <a href="#rid139">
          139
         </a>
         ]. The severity of radiographic hip involvement correlates with more severe spinal disease [
         <a href="#rid168">
          168
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3725387889">
         <span class="h2">
          Peripheral arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Radiographs of peripheral joints in patients with axSpA and peripheral SpA are often unremarkable and do not show the same type of erosions seen in rheumatoid arthritis (RA). An exception is in patients with psoriatic arthritis, in whom both osteoproliferative and osteodestructive lesions may be seen. Peripheral joint changes in SpA are described separately. (See
         <a class="medical medical_review" href="/z/d/html/7795.html" rel="external">
          "Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults", section on 'Imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">
          "Clinical manifestations and diagnosis of psoriatic arthritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3053173547">
         <span class="h2">
          Enthesitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The combined use of B-mode and power Doppler ultrasound (PDUS) can demonstrate changes consistent with peripheral enthesitis in patients with SpA, including findings of hypoechogenicity, increased thickness of the tendon insertion, calcifications, enthesophytes (bone spurs), and Doppler activity  (
         <a class="graphic graphic_diagnosticimage graphicRef95555 graphicRef95556" href="/z/d/graphic/95555.html" rel="external">
          image 20A-B
         </a>
         ) [
         <a href="#rid169">
          169,170
         </a>
         ]. Enthesitis can also be seen using MRI, showing both soft tissue changes and intraosseous inflammation [
         <a href="#rid171">
          171
         </a>
         ]. Abnormalities that can be seen include the presence of BME, soft tissue edema, changes in tendon thickness, erosions or enthesophytes in the adjacent bones, and fluid around tendons or adjacent to the bursa [
         <a href="#rid172">
          172
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H36">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/16164.html" rel="external">
          "Patient education: Ankylosing spondylitis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/577.html" rel="external">
          "Patient education: Axial spondyloarthritis, including ankylosing spondylitis (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11443893">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nomenclature and classification
         </strong>
         – Axial spondyloarthritis (axSpA) consists of ankylosing spondylitis (AS) and nonradiographic axSpA (nr-axSpA), which are characterized by symptoms of spinal inflammation and other features shared with spondyloarthritis (SpA) in general  (
         <a class="graphic graphic_table graphicRef96419" href="/z/d/graphic/96419.html" rel="external">
          table 1
         </a>
         ). AS can potentially lead to disabling spinal fusion and hyperkyphosis  (
         <a class="graphic graphic_picture graphicRef55095" href="/z/d/graphic/55095.html" rel="external">
          picture 1
         </a>
         ). (See
         <a class="local">
          'Nomenclature and classification'
         </a>
         above and
         <a class="local">
          'Musculoskeletal symptoms and findings'
         </a>
         above and
         <a class="local">
          'Musculoskeletal imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Estimates of the prevalence of axSpA in the United States are 1.0 to 1.4 percent. Globally, the prevalence varies depending upon the ethnic group and with the prevalence of human leukocyte antigen (HLA) B27. The prevalence of AS is approximately 5 to 6 percent among people who are HLA-B27-positive. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Musculoskeletal symptoms
         </strong>
         – The predominant symptom of axSpA is chronic back pain, which is frequently inflammatory in character. Inflammatory low back pain is characterized by age of onset &lt;40 years, insidious onset, association with morning stiffness, improvement with exercise but not with rest, and pain at night. AxSpA patients may also have peripheral arthritis, enthesitis  (
         <a class="graphic graphic_picture graphicRef96430" href="/z/d/graphic/96430.html" rel="external">
          picture 2
         </a>
         ), and dactylitis  (
         <a class="graphic graphic_picture graphicRef95915 graphicRef96458" href="/z/d/graphic/95915.html" rel="external">
          picture 3A-B
         </a>
         ). (See
         <a class="local">
          'Musculoskeletal symptoms and findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Extraarticular manifestations
         </strong>
         – Extraarticular manifestations may include anterior uveitis, psoriasis, and symptomatic as well as asymptomatic inflammatory bowel disease (IBD). Additional comorbidities include, for example, cardiovascular diseases. Complications may also occur. In AS, there is a significantly increased risk of vertebral fractures  (
         <a class="graphic graphic_diagnosticimage graphicRef94271" href="/z/d/graphic/94271.html" rel="external">
          image 1
         </a>
         ) from low-impact trauma related to spinal rigidity and low bone mineral density (BMD). (See
         <a class="local">
          'Extraarticular manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory findings
         </strong>
         – Laboratory findings are generally nonspecific and may include the presence of HLA-B27. An elevated acute phase response may be present, including an elevated erythrocyte sedimentation rate (ESR) and elevated C-reactive protein (CRP), but a normal ESR and CRP do not exclude axSpA or active disease. (See
         <a class="local">
          'Laboratory findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Musculoskeletal imaging
         </strong>
         – Definite changes on plain (conventional) radiography are characteristic of AS  (
         <a class="graphic graphic_diagnosticimage graphicRef68009 graphicRef58791" href="/z/d/graphic/68009.html" rel="external">
          image 7A
         </a>
         ), while patients with nr-axSpA by definition exhibit normal or minimally abnormal radiography of the SI joints but may have abnormal MRI findings (eg, bone marrow edema [BME]  (
         <a class="graphic graphic_diagnosticimage graphicRef74986" href="/z/d/graphic/74986.html" rel="external">
          image 8
         </a>
         )) of the joints that support the diagnosis of axSpA. Radiographic findings of the sacroiliac (SI) joints range from subtle joint-space narrowing and sclerosis to erosive change and may eventually result in bony ankylosis (fusion). Radiographic changes may also occur in the spine, particularly in patients with AS  (
         <a class="graphic graphic_diagnosticimage graphicRef69803" href="/z/d/graphic/69803.html" rel="external">
          image 12
         </a>
         ). (See
         <a class="local">
          'Musculoskeletal imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2895073049">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges David Yu, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Sepriano A, Ramiro S, van der Heijde D, et al. What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts. Ann Rheum Dis 2020; 79:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol 2021; 17:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelena X, López-Medina C, Marzo-Ortega H. Non-radiographic versus radiographic axSpA: what's in a name? Rheumatology (Oxford) 2020; 59:iv18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marzo-Ortega H. Axial spondyloarthritis: coming of age. Rheumatology (Oxford) 2020; 59:iv1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deodhar A, Strand V, Kay J, Braun J. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis 2016; 75:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68 Suppl 2:ii1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiltz U, Baraliakos X, Karakostas P, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (Hoboken) 2012; 64:1415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Protopopov M, Poddubnyy D. Radiographic progression in non-radiographic axial spondyloarthritis. Expert Rev Clin Immunol 2018; 14:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Tubergen A, Weber U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol 2012; 8:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strand V, Rao SA, Shillington AC, et al. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res (Hoboken) 2013; 65:1299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 2005; 52:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dean LE, Jones GT, MacDonald AG, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 2014; 53:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21:2281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol 1995; 34:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reveille JD, Weisman MH. The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 2013; 345:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reveille JD, Hirsch R, Dillon CF, et al. The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis Rheum 2012; 64:1407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reveille JD. Epidemiology of spondyloarthritis in North America. Am J Med Sci 2011; 341:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000; 59:883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morin M, Hellgren K, Frisell T. Familial aggregation and heritability of ankylosing spondylitis - a Swedish nested case-control study. Rheumatology (Oxford) 2020; 59:1695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter N, Williamson L, Kennedy LG, et al. Susceptibility to ankylosing spondylitis. Rheumatology (Oxford) 2000; 39:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carbone LD, Cooper C, Michet CJ, et al. Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing? Arthritis Rheum 1992; 35:1476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Winter JJ, van Mens LJ, van der Heijde D, et al. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 2016; 18:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson DA, Kaplan RM, Kurina LM, Weisman MH. Incidence of Ankylosing Spondylitis Among Male and Female United States Army Personnel. Arthritis Care Res (Hoboken) 2023; 75:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011; 70:1369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           López-Medina C, Molto A, Sieper J, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open 2021; 7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009; 68:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006; 54:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977; 237:2613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weisman MH. Inflammatory back pain: the United States perspective. Rheum Dis Clin North Am 2012; 38:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roussou E, Sultana S. Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides. Clin Rheumatol 2011; 30:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carette S, Graham D, Little H, et al. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983; 26:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vosse D, van der Heijde D, Landewé R, et al. Determinants of hyperkyphosis in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawacha Z, Carraro E, Del Din S, et al. Biomechanical assessment of balance and posture in subjects with ankylosing spondylitis. J Neuroeng Rehabil 2012; 9:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braun A, Gnann H, Saracbasi E, et al. Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27. Rheumatology (Oxford) 2013; 52:1418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vander Cruyssen B, Muñoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) 2010; 49:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           López-Medina C, Castro-Villegas MC, Collantes-Estévez E. Hip and Shoulder Involvement and Their Management in Axial Spondyloarthritis: a Current Review. Curr Rheumatol Rep 2020; 22:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bubová K, Forejtová Š, Zegzulková K, et al. Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort. BMJ Open 2019; 9:e024713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramos-Remus C, Major P, Gomez-Vargas A, et al. Temporomandibular joint osseous morphology in a consecutive sample of ankylosing spondylitis patients. Ann Rheum Dis 1997; 56:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciurea A, Scherer A, Exer P, et al. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum 2013; 65:3096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mielants H, Van den Bosch F. Extra-articular manifestations. Clin Exp Rheumatol 2009; 27:S56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bedaiwi M, Sari I, Thavaneswaran A, et al. Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort. J Rheumatol 2015; 42:2354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gossec L, Dougados M, D'Agostino MA, Fautrel B. Fatigue in early axial spondyloarthritis. Results from the French DESIR cohort. Joint Bone Spine 2016; 83:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maksymowych WP, Chou CT, Russell AS. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis 1995; 54:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 2008; 67:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolwijk C, Essers I, van Tubergen A, et al. The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis 2015; 74:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenbaum JT. Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease. Clin Rheumatol 2015; 34:999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz-Fernández S, Martín-Mola E. Uveitis. Best Pract Res Clin Rheumatol 2006; 20:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 1996; 121:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leirisalo-Repo M, Turunen U, Stenman S, et al. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994; 37:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Keyser F, Mielants H. The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface. J Rheumatol 2003; 30:2306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Praet L, Van den Bosch FE, Jacques P, et al. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 2013; 72:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           WRIGHT V, WATKINSON G. SACRO-ILIITIS AND ULCERATIVE COLITIS. Br Med J 1965; 2:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bandinelli F, Terenzi R, Giovannini L, et al. Occult radiological sacroiliac abnormalities in patients with inflammatory bowel disease who do not present signs or symptoms of axial spondylitis. Clin Exp Rheumatol 2014; 32:949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cantini F, Niccoli L, Nannini C, et al. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. J Rheumatol 2017; 44:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolwijk C, Pierik M, Landewé R, et al. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease. Can J Gastroenterol 2013; 27:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Erp SJ, Brakenhoff LK, van Gaalen FA, et al. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study. J Crohns Colitis 2016; 10:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 2006; 20:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011; 22:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pérez Alamino R, Maldonado Cocco JA, Citera G, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 2011; 38:1656.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edmunds L, Elswood J, Kennedy LG, Calin A. Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol 1991; 18:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wright GC, Kaine J, Deodhar A. Understanding differences between men and women with axial spondyloarthritis. Semin Arthritis Rheum 2020; 50:687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao SS, Robertson S, Reich T, et al. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford) 2020; 59:iv47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redeker I, Callhoff J, Hoffmann F, et al. The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis Res Ther 2020; 22:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rusman T, van Bentum RE, van der Horst-Bruinsma IE. Sex and gender differences in axial spondyloarthritis: myths and truths. Rheumatology (Oxford) 2020; 59:iv38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Weijden MA, Claushuis TA, Nazari T, et al. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol 2012; 31:1529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geusens P, Lems WF. Osteoimmunology and osteoporosis. Arthritis Res Ther 2011; 13:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011; 22:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gratacós J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 1999; 42:2319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dos Santos FP, Constantin A, Laroche M, et al. Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol 2001; 28:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moltó A, Etcheto A, van der Heijde D, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 2016; 75:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Maghraoui A, Borderie D, Cherruau B, et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 1999; 26:2205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karberg K, Zochling J, Sieper J, et al. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005; 32:1290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Zhang S, Zhu J, et al. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res Ther 2012; 14:R215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward MM, Reveille JD, Learch TJ, et al. Impact of ankylosing spondylitis on work and family life: comparisons with the US population. Arthritis Rheum 2008; 59:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brionez TF, Assassi S, Reveille JD, et al. Psychological correlates of self-reported disease activity in ankylosing spondylitis. J Rheumatol 2010; 37:829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sieper J, Hu X, Black CM, et al. Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis. Semin Arthritis Rheum 2017; 46:746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jang JH, Green CE, Assassi S, et al. The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. Rheumatology (Oxford) 2011; 50:2087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baysal O, Durmuş B, Ersoy Y, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 2011; 31:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordeev VS, Maksymowych WP, Evers SM, et al. Role of contextual factors in health-related quality of life in ankylosing spondylitis. Ann Rheum Dis 2010; 69:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu Q, Inman RD, Davis KD. Fatigue in ankylosing spondylitis is associated with the brain networks of sensory salience and attention. Arthritis Rheumatol 2014; 66:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hemington KS, Wu Q, Kucyi A, et al. Abnormal cross-network functional connectivity in chronic pain and its association with clinical symptoms. Brain Struct Funct 2016; 221:4203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bidad K, Gracey E, Hemington KS, et al. Pain in ankylosing spondylitis: a neuro-immune collaboration. Nat Rev Rheumatol 2017; 13:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones GT, Mallawaarachchi B, Shim J, et al. The prevalence of fibromyalgia in axial spondyloarthritis. Rheumatol Int 2020; 40:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Essers I, Stolwijk C, Boonen A, et al. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis 2016; 75:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haroon NN, Paterson JM, Li P, et al. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study. Ann Intern Med 2015; 163:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eriksson JK, Jacobsson L, Bengtsson K, Askling J. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 2017; 76:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eder L, Sadek M, McDonald-Blumer H, Gladman DD. Aortitis and spondyloarthritis--an unusual presentation: case report and review of the literature. Semin Arthritis Rheum 2010; 39:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slobodin G, Naschitz JE, Zuckerman E, et al. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol 2006; 24:S41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinsonneau U, Brondex A, Mansourati J, et al. Cardiovascular disease in patients with spondyloarthropathies. Joint Bone Spine 2008; 75:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 2006; 25:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozkan Y. Cardiac Involvement in Ankylosing Spondylitis. J Clin Med Res 2016; 8:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moyssakis I, Gialafos E, Vassiliou VA, et al. Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol 2009; 38:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim DY, Lee SJ, Ryu YJ, et al. Progressive Pulmonary Fibrocystic Changes of Both Upper Lungs in a Patient with Ankylosing Spondylitis. Tuberc Respir Dis (Seoul) 2015; 78:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berdal G, Halvorsen S, van der Heijde D, et al. Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study. Arthritis Res Ther 2012; 14:R19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boushea DK, Sundstrom WR. The pleuropulmonary manifestations of ankylosing spondylitis. Semin Arthritis Rheum 1989; 18:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kchir MM, Mtimet S, Kochbati S, et al. Bronchoalveolar lavage and transbronchial biopsy in spondyloarthropathies. J Rheumatol 1992; 19:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quismorio FP Jr. Pulmonary involvement in ankylosing spondylitis. Curr Opin Pulm Med 2006; 12:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiris A, Ozgocmen S, Kocakoc E, et al. Lung findings on high resolution CT in early ankylosing spondylitis. Eur J Radiol 2003; 47:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee CC, Lee SH, Chang IJ, et al. Spontaneous pneumothorax associated with ankylosing spondylitis. Rheumatology (Oxford) 2005; 44:1538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vosse D, Landewé R, van der Heijde D, et al. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009; 68:1839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pray C, Feroz NI, Nigil Haroon N. Bone Mineral Density and Fracture Risk in Ankylosing Spondylitis: A Meta-Analysis. Calcif Tissue Int 2017; 101:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mundwiler ML, Siddique K, Dym JM, et al. Complications of the spine in ankylosing spondylitis with a focus on deformity correction. Neurosurg Focus 2008; 24:E6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vosse D, Feldtkeller E, Erlendsson J, et al. Clinical vertebral fractures in patients with ankylosing spondylitis. J Rheumatol 2004; 31:1981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geusens P, De Winter L, Quaden D, et al. The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma. Arthritis Res Ther 2015; 17:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westerveld LA, Verlaan JJ, Oner FC. Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J 2009; 18:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leone A, Marino M, Dell'Atti C, et al. Spinal fractures in patients with ankylosing spondylitis. Rheumatol Int 2016; 36:1335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu H, Qian BP, Qiu Y, et al. Vertebral body or intervertebral disc wedging: which contributes more to thoracolumbar kyphosis in ankylosing spondylitis patients?: A retrospective study. Medicine (Baltimore) 2016; 95:e4855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsur AM, David P, Watad A, et al. Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study. J Gen Intern Med 2022; 37:3283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nugent M, Berney MJ, Morris S. Clinical outcomes following spinal fracture in patients with ankylosing spondylitis. Ir J Med Sci 2017; 186:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khedr EM, Rashad SM, Hamed SA, et al. Neurological complications of ankylosing spondylitis: neurophysiological assessment. Rheumatol Int 2009; 29:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chaudhary SB, Hullinger H, Vives MJ. Management of acute spinal fractures in ankylosing spondylitis. ISRN Rheumatol 2011; 2011:150484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thumbikat P, Hariharan RP, Ravichandran G, et al. Spinal cord injury in patients with ankylosing spondylitis: a 10-year review. Spine (Phila Pa 1976) 2007; 32:2989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramos-Remus C, Gomez-Vargas A, Guzman-Guzman JL, et al. Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol 1995; 22:2120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JS, Lee S, Bang SY, et al. Prevalence and risk factors of anterior atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol 2012; 39:2321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartleson JD, Cohen MD, Harrington TM, et al. Cauda equina syndrome secondary to long-standing ankylosing spondylitis. Ann Neurol 1983; 14:662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sant SM, O'Connell D. Cauda equina syndrome in ankylosing spondylitis: a case report and review of the literature. Clin Rheumatol 1995; 14:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SH, Lee EJ, Chung SW, et al. Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker. Rheumatol Int 2013; 33:1689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strobel ES, Fritschka E. Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 1998; 17:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy AR, Szabo SM, Rao SR, et al. Estimating the occurrence of renal complications among persons with ankylosing spondylitis. Arthritis Care Res (Hoboken) 2014; 66:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gratacós J, Collado A, Sanmartí R, et al. Coincidental amyloid nephropathy and IgA glomerulonephritis in a patient with ankylosing spondylitis. J Rheumatol 1993; 20:1613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lance NJ, Curran JJ. Amyloidosis in a case of ankylosing spondylitis with a review of the literature. J Rheumatol 1991; 18:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mokbel A, Lawson DO, Farrokhyar F. Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review. Clin Rheumatol 2021; 40:3465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mørk S, Voss A, Möller S, Bliddal M. Spondyloarthritis and Outcomes in Pregnancy and Labor: A Nationwide Register-Based Cohort Study. Arthritis Care Res (Hoboken) 2021; 73:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morin M, Frisell T, Stephansson O, Hellgren K. Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study. Lancet Rheumatol 2023; 5:e121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morin SN, Lix LM, Majumdar SR, Leslie WD. Temporal trends in the incidence of osteoporotic fractures. Curr Osteoporos Rep 2013; 11:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner Y, Strangfeld A, Molto A, et al. Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP). Ann Rheum Dis 2022; 81:1524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poddubnyy D, Sieper J. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 2014; 26:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002; 61 Suppl 3:iii8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niccoli L, Nannini C, Cassarà E, et al. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes. Int J Rheum Dis 2012; 15:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maksymowych WP. What do biomarkers tell us about the pathogenesis of ankylosing spondylitis? Arthritis Res Ther 2009; 11:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang KY, Hong YS, Park SH, Ju JH. Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis. Semin Arthritis Rheum 2015; 45:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laurent MR, Panayi GS. Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 1983; 42:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franssen MJ, van de Putte LB, Gribnau FW. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis 1985; 44:766.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omar A, Sari I, Bedaiwi M, et al. Analysis of dedicated sacroiliac views to improve reliability of conventional pelvic radiographs. Rheumatology (Oxford) 2017; 56:1740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jang JH, Ward MM, Rucker AN, et al. Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology 2011; 258:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poddubnyy D, Brandt H, Vahldiek J, et al. The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann Rheum Dis 2012; 71:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Berg R, de Hooge M, van Gaalen F, et al. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 2013; 52:1492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361.
          </a>
         </li>
         <li class="breakAll">
          Bennett PH, Burch TA. Population Studies of the Rheumatic Diseases, Excerpta Medica Foundation, Amsterdam 1968. p.456-457.
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Berg R, Lenczner G, Feydy A, et al. Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort. Arthritis Rheumatol 2014; 66:2403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Navallas M, Ares J, Beltrán B, et al. Sacroiliitis associated with axial spondyloarthropathy: new concepts and latest trends. Radiographics 2013; 33:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber U, Jurik AG, Lambert RG, Maksymowych WP. Imaging in Spondyloarthritis: Controversies in Recognition of Early Disease. Curr Rheumatol Rep 2016; 18:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68:1520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambert RG, Bakker PA, van der Heijde D, et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 2016; 75:1958.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marzo-Ortega H, McGonagle D, O'Connor P, et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009; 68:1721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber U, Lambert RG, Østergaard M, et al. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 2010; 62:3048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arnbak B, Grethe Jurik A, Hørslev-Petersen K, et al. Associations between spondyloarthritis features and magnetic resonance imaging findings: A cross-sectional analysis of 1,020 patients with persistent low back pain. Arthritis Rheumatol 2016; 68:892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber U, Jurik AG, Zejden A, et al. Frequency and Anatomic Distribution of Magnetic Resonance Imaging Features in the Sacroiliac Joints of Young Athletes: Exploring "Background Noise" Toward a Data-Driven Definition of Sacroiliitis in Early Spondyloarthritis. Arthritis Rheumatol 2018; 70:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Hooge M, van den Berg R, Navarro-Compán V, et al. Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis? Ann Rheum Dis 2016; 75:1308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber U, Pedersen SJ, Østergaard M, et al. Can erosions on MRI of the sacroiliac joints be reliably detected in patients with ankylosing spondylitis? - A cross-sectional study. Arthritis Res Ther 2012; 14:R124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuite MJ. Sacroiliac joint imaging. Semin Musculoskelet Radiol 2008; 12:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diekhoff T, Hermann KG, Greese J, et al. Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: Results from the SIMACT study. Ann Rheum Dis 2017; 76:1502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandl P, Navarro-Compán V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015; 74:1327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aufdermaur M. Pathogenesis of square bodies in ankylosing spondylitis. Ann Rheum Dis 1989; 48:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baraliakos X, Maksymowych WP. Imaging in the diagnosis and management of axial spondyloarthritis. Best Pract Res Clin Rheumatol 2016; 30:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeong H, Yoon JY, Park EJ, et al. Clinical characteristics of nonradiographic axial spondyloarthritis in Korea: a comparison with ankylosing spondylitis. Int J Rheum Dis 2015; 18:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Heijde D, Landewé R. Imaging in spondylitis. Curr Opin Rheumatol 2005; 17:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Heijde D, Sieper J, Maksymowych WP, et al. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol 2014; 66:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hermann KG, Baraliakos X, van der Heijde DM, et al. Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis 2012; 71:1278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramiro S, van Tubergen A, van der Heijde D, et al. Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis. Arthritis Rheumatol 2014; 66:2773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2015; 74:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward MM, Learch TJ, Gensler LS, et al. Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease. Arthritis Care Res (Hoboken) 2013; 65:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dwosh IL, Resnick D, Becker MA. Hip involvement in ankylosing spondylitis. Arthritis Rheum 1976; 19:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baraliakos X, Braun J. Hip involvement in ankylosing spondylitis: what is the verdict? Rheumatology (Oxford) 2010; 49:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terslev L, Naredo E, Iagnocco A, et al. Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise. Arthritis Care Res (Hoboken) 2014; 66:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Agostino MA, Aegerter P, Bechara K, et al. How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography. Ann Rheum Dis 2011; 70:1433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poggenborg RP, Eshed I, Østergaard M, et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination. Ann Rheum Dis 2015; 74:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eshed I, Bollow M, McGonagle DG, et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis 2007; 66:1553.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7785 Version 36.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31980546" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33361770" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Axial spondyloarthritis: concept, construct, classification and implications for therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19248087" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33053190" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Non-radiographic versus radiographic axSpA: what's in a name?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33053189" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Axial spondyloarthritis: coming of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26768406" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19433414" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19297344" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21109520" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22505331" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29774755" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Radiographic progression in non-radiographic axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22450552" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Diagnosis and classification in spondyloarthritis: identifying a chameleon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23436774" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15818678" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24324212" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Global prevalence of ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7699629" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8542211" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Inflammatory back pain in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23841117" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22139851" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21430444" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Epidemiology of spondyloarthritis in North America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11053066" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31687771" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Familial aggregation and heritability of ankylosing spondylitis - a Swedish nested case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10817782" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Susceptibility to ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1472124" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27586785" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34459565" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Incidence of Ankylosing Spondylitis Among Male and Female United States Army Personnel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21622969" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33462157" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19147614" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16447233" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/140252" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical history as a screening test for ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23083751" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Inflammatory back pain: the United States perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20882310" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6600615" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The natural disease course of ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16219704" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Determinants of hyperkyphosis in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22931459" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Biomechanical assessment of balance and posture in subjects with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23559574" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19605374" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32705356" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Hip and Shoulder Involvement and Their Management in Axial Spondyloarthritis: a Current Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30944131" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9068282" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Temporomandibular joint osseous morphology in a consecutive sample of ankylosing spondylitis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23983141" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Tumor necrosis factorαinhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19822047" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Extra-articular manifestations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26523020" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26709252" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Fatigue in early axial spondyloarthritis. Results from the French DESIR cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7702400" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17962239" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23999006" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24658834" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25953065" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16777578" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8554080" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Clinical features and associated systemic diseases of HLA-B27 uveitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8129761" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : High frequency of silent inflammatory bowel disease in spondylarthropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14677167" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23139267" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14337734" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : SACRO-ILIITIS AND ULCERATIVE COLITIS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25152017" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Occult radiological sacroiliac abnormalities in patients with inflammatory bowel disease who do not present signs or symptoms of axial spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28412702" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23616957" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26512134" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16777576" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Ankylosing spondylitis and bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22075279" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21632676" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1865416" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32521322" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Understanding differences between men and women with axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33053193" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32912264" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33053194" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Sex and gender differences in axial spondyloarthritis: myths and truths.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22706444" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21996023" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Osteoimmunology and osteoporosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20552328" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Osteoporosis in inflammatory joint diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10555026" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11296956" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Whole body and regional bone mineral density in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26489703" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10529141" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Osteoporosis, body composition, and bone turnover in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15996067" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23058191" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18383414" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Impact of ankylosing spondylitis on work and family life: comparisons with the US population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20156952" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Psychological correlates of self-reported disease activity in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27855973" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21875876" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20221605" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19282311" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Role of contextual factors in health-related quality of life in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24504801" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Fatigue in ankylosing spondylitis is associated with the brain networks of sensory salience and attention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26669874" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Abnormal cross-network functional connectivity in chronic pain and its association with clinical symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28615730" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Pain in ankylosing spondylitis: a neuro-immune collaboration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32556474" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The prevalence of fibromyalgia in axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25362044" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26258401" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27283333" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19217648" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Aortitis and spondyloarthritis--an unusual presentation: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16859596" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Aortic involvement in rheumatic diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17913549" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Cardiovascular disease in patients with spondyloarthropathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16247583" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27222669" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Cardiac Involvement in Ankylosing Spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19229673" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26508946" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Progressive Pulmonary Fibrocystic Changes of Both Upper Lungs in a Patient with Ankylosing Spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22277377" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2658070" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : The pleuropulmonary manifestations of ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1404128" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Bronchoalveolar lavage and transbronchial biopsy in spondyloarthropathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16926649" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Pulmonary involvement in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12810227" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Lung findings on high resolution CT in early ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16105907" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Spontaneous pneumothorax associated with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19066179" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28421263" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Bone Mineral Density and Fracture Risk in Ankylosing Spondylitis: A Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18290744" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Complications of the spine in ankylosing spondylitis with a focus on deformity correction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15468363" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Clinical vertebral fractures in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26493218" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18791749" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27379763" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Spinal fractures in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27661026" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Vertebral body or intervertebral disc wedging: which contributes more to thoracolumbar kyphosis in ankylosing spondylitis patients?: A retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35411534" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28150118" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Clinical outcomes following spinal fracture in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19153738" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Neurological complications of ankylosing spondylitis: neurophysiological assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22389792" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Management of acute spinal fractures in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18091492" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Spinal cord injury in patients with ankylosing spondylitis: a 10-year review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8596154" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23027892" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Prevalence and risk factors of anterior atlantoaxial subluxation in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6651250" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Cauda equina syndrome secondary to long-standing ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7789067" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Cauda equina syndrome in ankylosing spondylitis: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23269570" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9890685" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24106183" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Estimating the occurrence of renal complications among persons with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8164228" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Coincidental amyloid nephropathy and IgA glomerulonephritis in a patient with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2023177" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Amyloidosis in a case of ankylosing spondylitis with a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33464430" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31758739" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Spondyloarthritis and Outcomes in Pregnancy and Labor: A Nationwide Register-Based Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/38251608" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24078485" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Temporal trends in the incidence of osteoporotic fractures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35961759" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24807404" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12381506" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Ankylosing spondylitis: an overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22324947" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFαdrugs and therapy-induced changes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19183433" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25895696" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6605119" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4062389" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28957558" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Analysis of dedicated sacroiliac views to improve reliability of conventional pelvic radiographs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20971774" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22915622" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23650623" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6231933" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6231933" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24909765" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23842966" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Sacroiliitis associated with axial spondyloarthropathy: new concepts and latest trends.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27435070" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Imaging in Spondyloarthritis: Controversies in Recognition of Early Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19454404" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26768408" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19019894" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20496416" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26681230" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Associations between spondyloarthritis features and magnetic resonance imaging findings: A cross-sectional analysis of 1,020 patients with persistent low back pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29430880" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Frequency and Anatomic Distribution of Magnetic Resonance Imaging Features in the Sacroiliac Joints of Young Athletes: Exploring "Background Noise" Toward a Data-Driven Definition of Sacroiliitis in Early Spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26286018" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22626458" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Can erosions on MRI of the sacroiliac joints be reliably detected in patients with ankylosing spondylitis? - A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18382946" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Sacroiliac joint imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28283515" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: Results from the SIMACT study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25837448" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2782972" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Pathogenesis of square bodies in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27931957" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Imaging in the diagnosis and management of axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25195726" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Clinical characteristics of nonradiographic axial spondyloarthritis in Korea: a comparison with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15956837" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Imaging in spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24574227" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22586174" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25048876" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23956249" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23042639" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/942499" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Hip involvement in ankylosing spondylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19755506" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : Hip involvement in ankylosing spondylitis: what is the verdict?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24151222" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21586438" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24389294" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17526551" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : MRI of enthesitis of the appendicular skeleton in spondyloarthritis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
